Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOTECH Director's Dealing 2014

Feb 24, 2014

9301_dirs_2014-02-24_2144c5fd-355f-48b9-b7b4-f71e77ecc2a9.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

THE BIOTECH GROWTH TRUST PLC - Director/PDMR Shareholding

PR Newswire

London, February 24

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONSThis form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1).(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.PLEASE COMPLETE ALL RELEVANT BOXES IN BLOCK CAPITAL LETTERS.1. Name of the issuer:THE BIOTECH GROWTH TRUST PLC2. State whether the notification relates to: i. a transaction notified in accordance with DR 3.1.2R; orii. a disclosure made in accordance with LR9.8.6R(1); or(iii) a disclosure made in accordance with section 793 of the Companies Act2006(i)3. Name of person discharging managerial responsibilities/director:MR JONATHAN SILVERSTEIN (PERSON DISCHARGING MANAGERIAL RESPONSIBILITY)4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person:AS IN 3 ABOVE5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest:AS IN 3 ABOVE6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares:ORDINARY 25p SHARES7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them:NOT STATED8. State the nature of the transaction:DISPOSAL9. Number of shares, debentures or financial instruments relating to sharesacquired:NOT APPLICABLE10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage):NOT APPLICABLE11. Number of shares, debentures or financial instruments relating to sharesdisposed:10,000 ORDINARY SHARES12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage):0.015%13. Price per share or value of transaction:493.3687p PER SHARE14. Date and place of transaction:04 FEBRUARY 2014 - LONDON15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage):NIL ORDINARY SHARES0.0%16. Date issuer informed of transaction:21 FEBRUARY 2014If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes17. Date of grant:-18. Period during which or date on which it can be exercised:-19. Total amount paid (if any) for grant of the option:-20. Description of shares or debentures involved (class and number):-21. Exercise price (if fixed at time of grant) or indication that price is tobe fixed at the time of exercise:-22. Total number of shares or debentures over which options held followingnotification:-23. Any additional information:24. Name of contact and telephone number for queries:MARK POPE, COMPANY SECRETARYTEL: 020 3 008 4913Name and signature of duly authorised officer of issuer responsible for makingnotification: MARK POPEDate of notification:24 FEBRUARY 2014 - END -